JP2009517473A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517473A5
JP2009517473A5 JP2008543378A JP2008543378A JP2009517473A5 JP 2009517473 A5 JP2009517473 A5 JP 2009517473A5 JP 2008543378 A JP2008543378 A JP 2008543378A JP 2008543378 A JP2008543378 A JP 2008543378A JP 2009517473 A5 JP2009517473 A5 JP 2009517473A5
Authority
JP
Japan
Prior art keywords
bcaa
protein
individual
precursor
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008543378A
Other languages
English (en)
Japanese (ja)
Other versions
JP5260303B2 (ja
JP2009517473A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/045497 external-priority patent/WO2007064618A1/en
Publication of JP2009517473A publication Critical patent/JP2009517473A/ja
Publication of JP2009517473A5 publication Critical patent/JP2009517473A5/ja
Application granted granted Critical
Publication of JP5260303B2 publication Critical patent/JP5260303B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008543378A 2005-11-30 2006-11-28 筋肉損失の治療のための方法 Expired - Fee Related JP5260303B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74109205P 2005-11-30 2005-11-30
US60/741,092 2005-11-30
US78094106P 2006-03-09 2006-03-09
US60/780,941 2006-03-09
PCT/US2006/045497 WO2007064618A1 (en) 2005-11-30 2006-11-28 Methods for the treatment of muscle loss

Publications (3)

Publication Number Publication Date
JP2009517473A JP2009517473A (ja) 2009-04-30
JP2009517473A5 true JP2009517473A5 (https=) 2010-01-28
JP5260303B2 JP5260303B2 (ja) 2013-08-14

Family

ID=37806127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008543378A Expired - Fee Related JP5260303B2 (ja) 2005-11-30 2006-11-28 筋肉損失の治療のための方法

Country Status (17)

Country Link
US (1) US8329646B2 (https=)
EP (1) EP1957061B1 (https=)
JP (1) JP5260303B2 (https=)
CN (1) CN101316582A (https=)
AT (1) ATE508745T1 (https=)
AU (1) AU2006320670B8 (https=)
BR (1) BRPI0619179A2 (https=)
CA (1) CA2631647A1 (https=)
DK (1) DK1957061T3 (https=)
ES (1) ES2363442T3 (https=)
IL (1) IL191374A0 (https=)
MY (1) MY147489A (https=)
PT (1) PT1957061E (https=)
RU (1) RU2414897C2 (https=)
SG (1) SG163600A1 (https=)
WO (1) WO2007064618A1 (https=)
ZA (1) ZA200805657B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101282657A (zh) * 2005-10-28 2008-10-08 雀巢技术公司 支链氨基酸的使用方法
DE102007016715A1 (de) * 2007-04-04 2008-10-09 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren
US20110077198A1 (en) * 2007-11-26 2011-03-31 Michael John Tisdale Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
CN101939011B (zh) 2008-02-07 2012-10-10 雀巢产品技术援助有限公司 用于影响由剧烈的体力活动中恢复的组合物和方法
US20090264363A1 (en) * 2008-03-26 2009-10-22 Ward Loren S Leucine-Rich Peptide Compositions and Methods for Isolation
US20130236447A1 (en) * 2008-12-23 2013-09-12 Carmel-Haifa University Economic Corp., Ltd. Cognitive function
US20120296403A1 (en) 2010-02-10 2012-11-22 Novartis Ag Methods and compounds for muscle growth
US20130330423A1 (en) * 2011-02-25 2013-12-12 Merck Patent Gmbh Composition to increase joint and/or postural stability
RU2454227C1 (ru) * 2011-04-05 2012-06-27 Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации Композиция для восстановления скелетных мышц и кости при скелетной травме
RU2631597C2 (ru) 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
CA2863809A1 (en) * 2012-02-06 2013-08-15 Ajinomoto Co., Inc. Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
US9700071B2 (en) 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
RU2634407C2 (ru) 2012-03-26 2017-10-26 Эксселла Хелт Инк. Фрагменты пищевых белков и способы их применения
EP2831098A4 (en) 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS
EP2831100A4 (en) 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHOD
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
SG10201709195TA (en) 2012-11-13 2017-12-28 Nusirt Sciences Inc Compositions and methods for increasing energy metabolism
RU2517576C1 (ru) * 2013-03-06 2014-05-27 Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук (ГНЦ РФ-ИМБП РАН) Средство для профилактики и снижения деструкции белков скелетных мышц при их атрофии, вызванной гипокинезией и/или гравитационной разгрузкой
ES2844199T3 (es) 2013-04-16 2021-07-21 Childrens Hospital Philadelphia Composiciones y métodos para el tratamiento de lesiones cerebrales
HK1221609A1 (zh) * 2013-05-01 2017-06-09 Abbott Laboratories 增强老化肌肉再生的方法
CN103416760B (zh) * 2013-08-28 2014-09-10 山东卫康生物医药科技有限公司 治疗和预防肌肉衰减综合症的五谷杂粮全营养配方食品
RU2016110800A (ru) 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
KR101668074B1 (ko) * 2015-02-12 2016-10-21 전북대학교산학협력단 Ｐｋｒ 저해제를 유효성분으로 포함하는 기관지 천식의 예방 또는 치료용 조성물
CN105747214A (zh) * 2016-02-26 2016-07-13 四川安益生物科技有限公司 一种支链氨基酸组合物
JP7077235B2 (ja) * 2016-12-05 2022-05-30 大塚製薬株式会社 筋萎縮抑制組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN107440126A (zh) * 2017-09-08 2017-12-08 天津活力达生物科技有限公司 一种缓解运动疲劳的蛋白粉及其制备方法
EP3780973A4 (en) * 2018-04-18 2022-01-26 Ingenious Ingredients, LP COMPOSITIONS AND THEIR USE TO PROMOTE MUSCLE GROWTH AND FUNCTION
RU2686086C1 (ru) * 2018-05-17 2019-04-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ коррекции пресаркопении или саркопении у пациента с адекватным потреблением основных нутриентов, получающего лечение программным гемодиализом
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
CA3143450A1 (en) * 2019-06-20 2020-12-24 Societe Des Produits Nestle S.A. Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids
IT201900010437A1 (it) * 2019-06-28 2020-12-28 Dompe Farm Spa Composizione per il trattamento del deperimento muscolare

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
US4677121A (en) 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
JPH03264525A (ja) * 1990-03-14 1991-11-25 Otsuka Pharmaceut Factory Inc アミノ酸輸液
US6608109B2 (en) 1991-11-20 2003-08-19 Allen Ann De Wees Composition comprising L-arginine as a muscle growth stimulant and use thereof
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
DE19757250A1 (de) * 1997-12-22 1999-07-01 Forssmann Wolf Georg Prof Dr Insulin-like growth factor binding protein und seine Verwendung
US5817695A (en) * 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
MXPA01002173A (es) * 1998-08-28 2003-07-14 Scios Inc Inhibidores de p38-alfa cinasa.
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
CZ20022927A3 (cs) 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US7199124B2 (en) * 2001-02-02 2007-04-03 Takeda Pharmaceutical Company Limited JNK inhibitor
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
FR2833012B1 (fr) 2001-12-04 2004-01-30 Centre Nat Rech Scient Peptides agonistes de l'hormone de croissance et leurs applications
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
US7820702B2 (en) * 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US20080058324A1 (en) * 2004-08-25 2008-03-06 Santhera Pharmaceuticals (Schweiz) Ag Alpha-Keto Carbonyl Calpain Inhibitors
CN101282657A (zh) * 2005-10-28 2008-10-08 雀巢技术公司 支链氨基酸的使用方法
US7790688B2 (en) * 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly

Similar Documents

Publication Publication Date Title
JP2009517473A5 (https=)
WO2007064618A8 (en) Methods for the treatment of muscle loss
JP2007527914A5 (https=)
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
JP2005518433A5 (https=)
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
SI2205244T1 (sl) Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
JP2011511805A5 (https=)
DK2043637T3 (da) Fremgangsmåder og medikamenter til administrering af ibuprofen
BRPI0710682B8 (pt) combinação farmacêutica compreendendo 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol e paracetamol
JP2013510169A5 (https=)
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
NO20082636L (no) Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
NO20064515L (no) Farmasoytisk preparat med kontrollert frigivelse av tolperison for oral administrering
JP2009505991A5 (https=)
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2010098625A2 (ko) 약제학적 제제
JP2009523124A5 (https=)
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
EA200701010A1 (ru) Препарат гепирона с высокой дозировкой и длительным высвобождением
JP2007230991A5 (https=)
JP2008545616A5 (https=)